|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
BIND Biosciences, Inc. CEO Scott Minick and Founder Omid Farokhzad Win Ernst & Young LLP New England Entrepreneur of the Year Award
6/22/2012 10:11:03 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called AccurinsTM, today announced that its Chief Executive Officer, Scott Minick, and its Founder and an Associate Professor at Harvard Medical School, Omid Farokhzad, M.D., have been awarded the prestigious Ernst & Young New England Entrepreneur of the Year in the category of Life Sciences. The Ernst & Young award recognizes accomplished entrepreneurs for their development of new technologies, improvement of quality of life, and creation of strong and vibrant corporations. Mr. Minick and Dr. Farokhzad were honored last night at an event hosted by Ernst & Young in Boston, Massachusetts.
|
|
|
|
|
|
|
|
|
|
|